Aprea Therapeutics
APRE
#11121
Rank
NZ$5.94 M
Marketcap
NZ$0.42
Share price
-53.56%
Change (1 day)
-79.91%
Change (1 year)

Earnings for Aprea Therapeutics (APRE)

Earnings in 2026 (TTM): -NZ$23.01 Million

According to Aprea Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$24.2 Million, an increase over its 2024 earnings that were of -NZ$26.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aprea Therapeutics from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$23.01 Million-4.9%
2025 -NZ$24.2 Million-7.58%
2024 -NZ$26.18 Million-7.45%
2023 -NZ$28.29 Million-58.6%
2022 -NZ$68.32 Million-0.2%
2021 -NZ$68.46 Million-29.09%
2020 -NZ$96.54 Million64.34%
2019 -NZ$58.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Magellan Health
MGLN
NZ$39.16 M-262.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
NZ$0.27 B-1,229.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
NZ$0.23 B-1,079.35%๐Ÿ‡บ๐Ÿ‡ธ USA